Loading...

Sue Yom, MD, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentRadiation Oncology
Address1600 Divisadero
San Francisco CA 94115
Phone415-353-7175
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of PennsylvaniaM.D.2002School of Medicine

    Collapse Overview 
    Collapse Overview
    I am a radiation oncologist who specializes in the treatment of head and neck, skin and thoracic cancers.

    Major research interests include:

    - clinical management of head and neck, lung, and skin cancers
    - technical innovations in radiation therapy
    - novel combinations of targeted therapy and immunotherapy with radiation
    - virally driven cancers such as humanpapillomavirus, Epstein-Barr virus, and Merkel cell polyomavirus
    - biomarkers for radiation responsiveness or resistance
    - radioprotectants
    - preclinical development of radiation sensitizers
    - patient-centered decision making
    - outcomes research in the context of high-value care


    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zietman AL, Yom S. The Red Journal's Outstanding Reviewer Awards for 2016. Int J Radiat Oncol Biol Phys. 2017 Sep 01; 99(1):1-2. PMID: 28816135.
      View in: PubMed
    2. Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom S, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Aug 04; JCO2016720748. PMID: 28777690.
      View in: PubMed
    3. Koyfman SA, Yom S. Clinical Research Ethics: Considerations for the Radiation Oncologist. Int J Radiat Oncol Biol Phys. 2017 Oct 01; 99(2):259-264. PMID: 28871967.
      View in: PubMed
    4. Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom S, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 Jun; 15(6):761-770. PMID: 28596256.
      View in: PubMed
    5. Yom S, Mallen-St Clair J, Ha PK. Controversies in Postoperative Irradiation of Oropharyngeal Cancer After Transoral Surgery. Surg Oncol Clin N Am. 2017 Jul; 26(3):357-370. PMID: 28576176.
      View in: PubMed
    6. Kim KY, Le QT, Yom S, Pinsky BA, Bratman SV, Ng RH, El Mubarak HS, Chan KC, Sander M, Conley BA. Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. J Natl Cancer Inst. 2017 04 01; 109(4). PMID: 28376165.
      View in: PubMed
    7. Ghosh P, Lazar AA, Ryan WR, Yom S. A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer. 2017 Aug; 25(8):2611-2618. PMID: 28353039.
      View in: PubMed
    8. Kim KY, Le QT, Yom S, Ng RHW, Chan KCA, Bratman SV, Welch JJ, Divi RL, Petryshyn RA, Conley BA. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients. Int J Radiat Oncol Biol Phys. 2017 Aug 01; 98(5):996-1001. PMID: 28721913.
      View in: PubMed
    9. Yom S. A Larynx Best Preserved, but by Radiation or Formalin? Int J Radiat Oncol Biol Phys. 2017 Apr 01; 97(5):889-890. PMID: 28333005.
      View in: PubMed
    10. Boreta L, Yom S. Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer? Ann Transl Med. 2017 Mar; 5(5):108. PMID: 28361073.
      View in: PubMed
    11. Chapman CH, Parvathaneni U, Yom S. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma. Future Oncol. 2017 Mar; 13(7):581-584. PMID: 28169580.
      View in: PubMed
    12. Chapman CH, Parvathaneni U, Yom S. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites. Future Oncol. 2017 Mar; 13(6):469-475. PMID: 28169592.
      View in: PubMed
    13. Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom S, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 2017 Jun 01; 123(11):2054-2060. PMID: 28171708.
      View in: PubMed
    14. Kim H, Chen J, Phillips J, Pukala J, Yom S, Kirby N. Validating Dose Uncertainty Estimates Produced by AUTODIRECT: An Automated Program to Evaluate Deformable Image Registration Accuracy. Technol Cancer Res Treat. 2017 Jan 01; 1533034617708076. PMID: 28490254.
      View in: PubMed
    15. Paulsson AK, Yom S, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M. Respiration-Induced Intraorgan Deformation of the Liver. Technol Cancer Res Treat. 2017 Jan 01; 1533034616687193. PMID: 28071340.
      View in: PubMed
    16. Palma DA, Yom S, Bennett KE, Corry J, Zietman AL. Introducing: The Red Journal Gray Zone. Int J Radiat Oncol Biol Phys. 2017 Jan 01; 97(1):1. PMID: 27979440.
      View in: PubMed
    17. Yom S. The Tonsillar Fossa Battleground. Int J Radiat Oncol Biol Phys. 2017 Jan 01; 97(1):1-2. PMID: 27979441.
      View in: PubMed
    18. Siddiqui F, Smith RV, Yom S, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head Neck. 2016 Dec 29. PMID: 28032679.
      View in: PubMed
    19. Yom S. Is Induction Chemotherapy Needed to Select Patients for Deintensified Treatment of Human Papillomavirus-Associated Oropharyngeal Cancer? J Clin Oncol. 2016 Dec 28; JCO2016710681. PMID: 28029316.
      View in: PubMed
    20. Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom S, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, Bruner DW. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification. J Pain Symptom Manage. 2017 Jan; 53(1):139-145.e2. PMID: 27899312.
      View in: PubMed
    21. Chan JW, Parvathaneni U, Yom S. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma. Future Oncol. 2016 Nov 23. PMID: 27875901.
      View in: PubMed
    22. Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom S, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncol. 2016 Nov 15. PMID: 27842456.
      View in: PubMed
    23. Braunstein S, Glastonbury CM, Chen J, Quivey JM, Yom S. Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation. AJNR Am J Neuroradiol. 2017 Jan; 38(1):146-153. PMID: 27811130.
      View in: PubMed
    24. Zevallos JP, Yom S. Redefining the Role of Surgical Management in the Evolving Landscape of Oropharyngeal Cancer. J Oncol Pract. 2016 Nov; 12(11):1185-1187. PMID: 27858535.
      View in: PubMed
    25. Yu Y, Mabray M, Silveira W, Shen PY, Ryan WR, Uzelac A, Yom S. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma. Head Neck. 2016 Oct 11. PMID: 27726241.
      View in: PubMed
    26. Kiang A, Weinberg VK, Cheung KH, Shugard E, Chen J, Quivey JM, Yom S. Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors. Radiat Oncol. 2016 Sep 26; 11(1):127. PMID: 27671196.
      View in: PubMed
    27. Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom S. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head Neck. 2016 Sep; 38(9):1299-309. PMID: 27330003.
      View in: PubMed
    28. Tan DS, Yom S, Tsao MS, Pass HI, Kelly K, Peled N, Yung RC, Wistuba II, Yatabe Y, Unger M, Mack PC, Wynes MW, Mitsudomi T, Weder W, Yankelevitz D, Herbst RS, Gandara DR, Carbone DP, Bunn PA, Mok TS, Hirsch FR. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. J Thorac Oncol. 2016 Jul; 11(7):946-63. PMID: 27229180.
      View in: PubMed
    29. Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom S. ACR Appropriateness criteria® for nasopharyngeal carcinoma. Head Neck. 2016 Jul; 38(7):979-86. PMID: 27131050.
      View in: PubMed
    30. Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom S. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy. J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7. PMID: 27020481.
      View in: PubMed
    31. Singer L, Calkins SM, E Horvai A, R Ryan W, Yom S. Xanthogranuloma in the heavily irradiated low neck in a patient with head and neck cancer. J Otolaryngol Head Neck Surg. 2016; 45(1):20. PMID: 27009318.
      View in: PubMed
    32. Anwar M, Yu Y, Glastonbury CM, El-Sayed IH, Yom S. Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e277-e281. PMID: 27687189.
      View in: PubMed
    33. Wyatt G, Pugh SL, Wong RK, Sagar S, Singh AK, Koyfman SA, Nguyen-Tân PF, Yom S, Cardinale FS, Sultanem K, Hodson I, Krempl GA, Lukaszczyk B, Yeh AM, Berk L. Xerostomia health-related quality of life: NRG oncology RTOG 0537. Qual Life Res. 2016 Sep; 25(9):2323-33. PMID: 26914104.
      View in: PubMed
    34. Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom S. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head Neck. 2016 Feb; 38(2):175-82. PMID: 26791005.
      View in: PubMed
    35. Chapman CH, Saba NF, Yom S. Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation? Ann Transl Med. 2016 Feb; 4(4):80. PMID: 27004227.
      View in: PubMed
    36. Corry J, Yom S. The Multidisciplinary Approach Needs to Extend Into Head and Neck Cancer Clinical Trials. Int J Radiat Oncol Biol Phys. 2016 Feb 1; 94(2):217-20. PMID: 26853330.
      View in: PubMed
    37. Yom S. The softer (and furrier) side of oncology. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):285-6. PMID: 27025162.
      View in: PubMed
    38. Yom S, Ganti AK, Dietz A. What's New in Head and Neck Cancer: Key Findings in 2015-2016 From ECCO/ESMO, ASTRO, and the Multidisciplinary Head and Neck Cancer Symposium. Am Soc Clin Oncol Educ Book. 2016; 35:176-83. PMID: 27249698.
      View in: PubMed
    39. Fakhry C, Yom S, Gillison ML. Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med. 2015 Dec 17; 373(25):2476. PMID: 26672855.
      View in: PubMed
    40. Yom S. HPV and oropharyngeal cancer: etiology and prognostic importance. Semin Cutan Med Surg. 2015 Dec; 34(4):178-81. PMID: 26650695.
      View in: PubMed
    41. Yom S, Gillison ML, Trotti AM. Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder. Int J Radiat Oncol Biol Phys. 2015 Dec 1; 93(5):986-8. PMID: 26581136.
      View in: PubMed
    42. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom S, McMillian N, Hughes M. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856. PMID: 26150579.
      View in: PubMed
    43. Yom S. Radiation treatment of head and neck cancer. Surg Oncol Clin N Am. 2015 Jul; 24(3):423-36. PMID: 25979392.
      View in: PubMed
    44. Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom S. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma. Br J Dermatol. 2015 Aug; 173(2):544-6. PMID: 25702621.
      View in: PubMed
    45. Heaton CM, Al-Shwaiheen F, Liu CS, Yom S, Ryan WR. Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation. Clin Otolaryngol. 2015 Jun; 40(3):260-5. PMID: 25641627.
      View in: PubMed
    46. Singer L, Yom S. Consolidative radiation therapy for extensive-stage small cell lung cancer. Transl Lung Cancer Res. 2015 Jun; 4(3):211-4. PMID: 26207205; PMCID: PMC4483471.
    47. Hemmat SM, Wang SJ, Uzelac A, Yom S, Ryan WR. The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma. ORL J Otorhinolaryngol Relat Spec. 2015; 77(3):132-40. PMID: 26022374.
      View in: PubMed
    48. Wong RK, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom S, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh J, Thakrar H, Pugh SL, Berk L. Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. Int J Radiat Oncol Biol Phys. 2015 Jun 1; 92(2):220-7. PMID: 25841622; PMCID: PMC4431932 [Available on 06/01/16].
    49. Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom S. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar; 42(3):1280-7. PMID: 25735283.
      View in: PubMed
    50. Axelrod RS, Sherman E, Garden A, Nguyen-Tan PF, Trotti A, Yom S, Zhang Q. Reply to D. Adkins et al. J Clin Oncol. 2015 Apr 1; 33(10):1224-5. PMID: 25713438.
      View in: PubMed
    51. Al-Shwaiheen FA, Wang SJ, Uzelac A, Yom S, Ryan WR. The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma. Am J Otolaryngol. 2015 May-Jun; 36(3):415-23. PMID: 25697087.
      View in: PubMed
    52. Yom S, Diehn M, Raben D. Molecular determinants of radiation response in non-small cell lung cancer. Semin Radiat Oncol. 2015 Apr; 25(2):67-77. PMID: 25771410.
      View in: PubMed
    53. Yom S. Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies. Semin Radiat Oncol. 2015 Apr; 25(2):93-9. PMID: 25771413.
      View in: PubMed
    54. Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom S. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014; 9:269. PMID: 25476839; PMCID: PMC4265326.
    55. Goepfert RP, Yom S, Ryan WR, Cheung SW. Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma. Laryngoscope. 2015 Apr; 125(4):869-76. PMID: 25388529.
      View in: PubMed
    56. Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom S. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb; 14(1):49-60. PMID: 24325136.
      View in: PubMed
    57. Fogh S, Yom S. Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician. Semin Oncol. 2014 Dec; 41(6):764-75. PMID: 25499635.
      View in: PubMed
    58. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom S, McMillian NR, Hughes M. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. PMID: 25313184.
      View in: PubMed
    59. Thariat J, Yom S, Sanguineti G, Corry J. Oncology scan--nodal regions, nodal regression, and molecular biomarkers: new thinking in head and neck radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):477-9. PMID: 25304942.
      View in: PubMed
    60. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom S, Axelrod RS. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50. PMID: 25154822; PMCID: PMC4162493.
    61. Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom S. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. Am J Clin Oncol. 2014 Aug; 37(4):350-5. PMID: 23357970.
      View in: PubMed
    62. Yom S, Cohen E. The ACR appropriateness criteria® for thyroid carcinoma: searching for consensus in a rapidly evolving area. Oral Oncol. 2014 Jun; 50(6):575-6. PMID: 24824114.
      View in: PubMed
    63. Salama JK, Golden DW, Yom S, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness Criteria® thyroid carcinoma. Oral Oncol. 2014 Jun; 50(6):577-86. PMID: 24824115.
      View in: PubMed
    64. Cooper JS, Yom S. Q&A with Dr Jay S. Cooper about Radiation Therapy Oncology Group 9003. Int J Radiat Oncol Biol Phys. 2014 May 1; 89(1):10-2. PMID: 24725685.
      View in: PubMed
    65. Yu J, Aldabagh B, Wang J, Yom S, El-Sayed I, Knott D, McGrath MH, Arron S. Multidisciplinary management of advanced basal cell carcinoma: report of four cases. J Drugs Dermatol. 2014 May; 13(5):601-6. PMID: 24809887.
      View in: PubMed
    66. Ouyang D, El-Sayed IH, Yom S. National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes. Laryngoscope. 2014 Jul; 124(7):1609-14. PMID: 24390781.
      View in: PubMed
    67. George JR, Yom S, Wang SJ. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis. Laryngoscope. 2014 Jul; 124(7):1603-8. PMID: 24318221.
      View in: PubMed
    68. Chainani-Wu N, Chang C, Gross AJ, Yom S, Silverman S. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar; 117(3):e261-3. PMID: 24528797.
      View in: PubMed
    69. George JR, Yom S, Wang SJ. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1118-26. PMID: 24051518.
      View in: PubMed
    70. Ridge JA, Lawson J, Yom S, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer. Head Neck. 2014 Jan; 36(1):3-8. PMID: 23696520.
      View in: PubMed
    71. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom S, McMillian NR, Hughes M. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23. PMID: 23946171.
      View in: PubMed
    72. Garg MK, Ridge JA, Yom S, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar; 35(3):465-6. PMID: 23386559.
      View in: PubMed
    73. Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom S. Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas. Invest New Drugs. 2013 Oct; 31(5):1136-41. PMID: 23354848.
      View in: PubMed
    74. Yom S. Oncology scan--head and neck cancers. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):3-5. PMID: 23236994.
      View in: PubMed
    75. Pejavar S, Yom S, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. PMID: 23289478.
      View in: PubMed
    76. Saba NF, Yom S, Haigentz M, El-Rayes B. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemother Res Pract. 2012; 2012:291421. PMID: 23320170; PMCID: PMC3540736.
    77. Graff P, Kirby N, Weinberg V, Chen J, Yom S, Lambert L, Pouliot J. The residual setup errors of different IGRT alignment procedures for head and neck IMRT and the resulting dosimetric impact. Int J Radiat Oncol Biol Phys. 2013 May 1; 86(1):170-6. PMID: 23245281.
      View in: PubMed
    78. Kono SA, Haigentz M, Yom S, Saba N. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract. 2012; 2012:901320. PMID: 23056941; PMCID: PMC3465896.
    79. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom S, Ang KK. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5):1198-205. PMID: 22749632; PMCID: PMC3465463.
    80. Ueda U, Chen J, Kirby N, Quivey J, Yom S, Pouliot J. SU-E-J-84: Investigating the Use of Deformable Algorithms to Register and Accumulate Dose to the Spinal Cord for Head-And-Neck Radiotherapy Patients. Med Phys. 2012 Jun; 39(6Part7):3671-3672. PMID: 28519820.
      View in: PubMed
    81. Yom S, Chen CP, Jahan TM, Jablons DM. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May; 7(5):945. PMID: 22722802.
      View in: PubMed
    82. Yeung AR, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yom S, Beitler JJ. ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck. 2012 May; 34(5):613-6. PMID: 22250010.
      View in: PubMed
    83. Graff P, Hu W, Yom S, Pouliot J. Does IGRT ensure target dose coverage of head and neck IMRT patients? Radiother Oncol. 2012 Jul; 104(1):83-90. PMID: 22146294.
      View in: PubMed
    84. Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom S. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol. 2011 Nov; 6(11):1857-64. PMID: 21964528.
      View in: PubMed
    85. Mannina EM, Pejavar SM, Glastonbury CM, van Zante A, Wang SJ, Yom S. Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review. Int J Otolaryngol. 2011; 2011:928240. PMID: 21785599; PMCID: PMC3139134.
    86. Yom S, Garden AS, Staerkel GA, Ginsberg LE, Morrison WH, Sturgis EM, Rosenthal DI, Myers JN, Edeiken-Monroe BS. Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer. AJNR Am J Neuroradiol. 2011 Sep; 32(8):1532-8. PMID: 21757532.
      View in: PubMed
    87. Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom S, Beitler JJ. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol. 2011 Jul; 47(7):554-9. PMID: 21664857.
      View in: PubMed
    88. McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom S, Beitler JJ. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1292-8. PMID: 21530100.
      View in: PubMed
    89. Chen CP, Wang SJ, van Zante A, Yom S. Stepwise regional and distant progression of recurrent pleomorphic adenoma. J Otolaryngol Head Neck Surg. 2011 Feb; 40(1):E5-10. PMID: 21303593.
      View in: PubMed
    90. Kangelaris GT, Yom S, Huang K, Wang SJ. Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma. Int J Otolaryngol. 2010; 2010. PMID: 20862388; PMCID: PMC2939390.
    91. Quon H, Yom S, Garg MK, Lawson J, McDonald MW, Ridge JA, Saba N, Salama J, Smith R, Yeung AR, Beitler JJ. ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. Curr Probl Cancer. 2010 May-Jun; 34(3):175-92. PMID: 20541056.
      View in: PubMed
    92. Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom S. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Med Phys. 2010 Apr; 37(4):1737-41. PMID: 20443494.
      View in: PubMed
    93. Tsuji SY, Hwang A, Weinberg V, Yom S, Quivey JM, Xia P. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 1; 77(3):707-14. PMID: 20231063.
      View in: PubMed
    94. Park CC, Yom S, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963-72. PMID: 20206016.
      View in: PubMed
    95. Sawkey D, Lu M, Morin O, Aubin M, Yom S, Gottschalk AR, Bani-Hashemi A, Faddegon BA. A diamond target for megavoltage cone-beam CT. Med Phys. 2010 Mar; 37(3):1246-53. PMID: 20384262.
      View in: PubMed
    96. Beadle BM, Jhingran A, Yom S, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1396-403. PMID: 19581056.
      View in: PubMed
    97. Cheung J, Aubry JF, Yom S, Gottschalk AR, Celi JC, Pouliot J. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):583-92. PMID: 19345518.
      View in: PubMed
    98. Hwang AB, Bacharach SL, Yom S, Weinberg VK, Quivey JM, Franc BL, Xia P. Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys. 2009 Feb 1; 73(2):578-84. PMID: 19084350.
      View in: PubMed
    99. Jin H, Tucker SL, Liu HH, Wei X, Yom S, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol. 2009 Jun; 91(3):427-32. PMID: 18937989.
      View in: PubMed
    100. Vitolo V, Millender LE, Quivey JM, Yom S, Schechter NR, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol. 2009 Feb; 90(2):213-20. PMID: 18926579.
      View in: PubMed
    101. Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom S, Phillips TL, Quivey JM. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer. 2008 Aug 1; 113(3):497-507. PMID: 18521908.
      View in: PubMed
    102. Aubry JF, Cheung J, Yom S, Gottschalk A, Aubin M, Morin O, Descovich M, Beaulieu L, Pouliot J. Sci-Thurs PM: Delivery-12: Correction and calibration of megavoltage cone-beam CT images for the calculation of the dose of the day. Med Phys. 2008 Jul; 35(7Part2):3401. PMID: 28512819.
      View in: PubMed
    103. Yom S, Frija EK, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J, Woo S. Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1193-8. PMID: 17967308.
      View in: PubMed
    104. Yom S, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007 May 1; 68(1):94-102. PMID: 17321067.
      View in: PubMed
    105. Yom S, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 1; 66(2):469-76. PMID: 16887292.
      View in: PubMed
    106. Yom S, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jun; 101(6):761-8. PMID: 16731397.
      View in: PubMed
    107. Yom S, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005 Aug; 28(4):385-92. PMID: 16062081.
      View in: PubMed
    108. Yom S, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9. PMID: 15492756.
      View in: PubMed
    109. Yom S, Rosenthal DI. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome? Nat Clin Pract Oncol. 2004 Nov; 1(1):14-5. PMID: 16264790.
      View in: PubMed
    110. de Crevoisier R, Ammor A, Court B, Wibault P, Chirat E, Fizazi K, Theodore C, Yom S, Haie-Meder C. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience. Radiother Oncol. 2004 Aug; 72(2):147-57. PMID: 15376367.
      View in: PubMed
    111. Yom S, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol. 2003 Jul; 78(1):75-81. PMID: 12929752.
      View in: PubMed
    112. Rosenthal DI, Yom S, Liu L, Machtay M, Algazy K, Weber RS, Weinstein GS, Chalian AA, Mille LK, Rockwell K, Tonda M, Schnipper E, Hershock D. A phase I study of SPI-077 (Stealth liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. Invest New Drugs. 2002 Aug; 20(3):343-9. PMID: 12201498.
      View in: PubMed
    Back to TOP